Biogen stock skyrockets on news FDA may back its Alzheimer’s drug
Biogen stock soared 36% today on news FDA apparently is set to recommend approval of its treatment for Alzheimer’s. Here’s what’s happening.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
